Hydroxychloroquine sulfate tablets for patients with recurrent implantation failure: a double-blind, randomized, placebo-controlled trial
ChiCTR2100047584 [Chinese Clinical Trial Registry (ChiCTR): registered on 20 June 2021]. LM2021267 [Ethics Committee of Peking University Third Hospital].
Authors
- Yimeng Ge (ORCID: https://orcid.org/0000-0001-8939-8681)
- Yifan Chu
- Y. L. Zhang
- Lei Li (ORCID: https://orcid.org/0000-0001-8723-3461)
- Yue Jing (ORCID: https://orcid.org/0000-0002-0273-3481)
- Jing Shi
- Zhuo-Yao Mai
- Dong-Lin Han
- Hui-Fen Xiang
- Hui Chen
- Gui-Min He
- Shu-Lin Yang
- Rong Li
- Jie Zhao
Institutions
- Hebei Medical University (CN)
- Ministry of Education of the People's Republic of China (CN)
- Sun Yat-sen University (CN)
- Anhui Medical University (CN)
- Peking University (CN)
- Reproductive Science Center (US)
- National Clinical Research Center for Digestive Diseases (CN)
- Ministry of Education (RO)
- Ministry of Education (SA)
- Sun Yat-sen Memorial Hospital (CN)
- Second Hospital of Hebei Medical University (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Peking University Third Hospital (CN)
- Tongji Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Trials
- Published
- 2026-01-30
- DOI
- https://doi.org/10.1186/s13063-026-09470-4
- Primary Topic
- Reproductive System and Pregnancy
- Type
- article
- Field-Weighted Citation Impact
- 0.00